Intellicell Biosciences

IntelliCell BioSciences is a regenerative medicine company. Its proprietary patent pending process involves the application of ultrasonic cavitation (sound waves) to the extracted adipose tissue for the separation of adult autologous vascular cells (AAVC’s) from the blood vessels in adult adipose (fat) tissue. These AAVC’s or stromal vascular fraction are a heterogeneous mixture of regenerative cells and autologous adult stem cells that promote the healing of injured tissue. AAVC’s contain adult stem cells, fibroblasts, growth factors, and other cellular components.